AKT2 损失会影响 BRAF 突变黑色素瘤转移
Siobhan K McRee1,2, Abraham L Bayer3,4, Jodie Pietruska2
1Program in Genetics, Graduate School of Biomedical Sciences, Tufts University, Boston, MA 02111, USA.
Cancers
|October 28, 2023
概括
黑色素瘤转移是由AKT2驱动的,而不是AKT1,这对初始瘤生长至关重要. 向AKT2可以通过抑制传播提供新的黑色素瘤治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 皮肤病学 皮肤病学
背景情况:
- 黑色素瘤是一种具有高转移潜力的致命皮肤癌,通常与BRAF突变和PTEN损失有关.
- 不受约束的PI3K/AKT信号传递有助于黑色素瘤的侵入性,但单个AKT异型的作用尚不清楚.
- 了解异形特异性功能对于开发向黑色素瘤治疗非常重要.
研究的目的:
- 研究AKT异型 (AKT1,AKT2,AKT3) 在黑色素瘤发病,进展和转移中的不同作用.
- 探索针对黑色素瘤治疗的特定AKT异型的治疗策略.
主要方法:
- 利用一种新的小鼠模型来检测黑色素瘤中的AKT异型特异性损失.
- 在人类转移性黑色素瘤细胞系中采用AKT异形特异性镇压.
- 分析了瘤的开始,扩散,迁移,入侵和转移性播种.
主要成果:
- AKT1对于黑色素瘤的发病和细胞增殖至关重要.
- AKT2对于原发性瘤形成是不可或缺的,但对于迁移,入侵和转移性播种至关重要.
- 抑制AKT2会损害糖解,并降低黑色素瘤细胞上皮层-介质酶转换 (EMT) 基因表达.
结论:
- AKT1和AKT2在黑色素瘤的发展和转移中发挥着不同的,非冗余的作用.
- AKT2是黑色素瘤细胞入侵和转移的关键驱动因素.
- 向AKT2可能是一个可行的治疗策略,以限制黑色素瘤的传播.
相关概念视频
02:30Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:12Loss of Tumor Suppressor Gene Functions
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K